An interventional study of Digital single-session cognitive behavioural therapy and Digital memory task in Depression / Major Depressive Disorder, Anxiety and Anxiety Disorder Generalized, sponsored by Brunel University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Brunel University · Not applicable, Interventional, and Treatment
The goal of this study is to learn if digital single-session cognitive behavioural therapy can treat mental health in adults. The main question it aims to answer is:
Researchers will compare digital single-session cognitive behavioural therapy to a control intervention (digital memory task) to see if digital single-session cognitive behavioural therapy works to treat mental health.
Participants will:
8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 110 is above the median of 84 across 6,869 interventional studies indexed under Depression.
Browse Depression studies →Brunel University is the lead sponsor of 11 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participant will receive digital single-session cognitive behavioural therapy.
Behavioral: Digital single-session cognitive behavioural therapy
Participant will receive a digital memory task.
Behavioral: Digital memory task
Participants complete one session of digital single-session therapy which takes approximately 45 minutes and is accessible via an online link.
Also known as: CBT, single session therapy
Participants complete one session of a digital memory task which take approximately 45 minutes and is accessible via an online link.
Change from baseline in PHQ-9 scores at 45 minutes post-intervention
Evaluates depressive symptoms from 0 (no symptoms) to 27 (severe symptoms).
Time frame: From baseline to 45 minutes post-intervention
Change from baseline in GAD-7 scores at 45 minutes post-intervention
Evaluates anxious symptoms from 0 (no symptoms) to 21 (severe symptoms).
Time frame: From baseline to 45 minutes post-intervention
Change from baseline in ATQ-30 scores at 45 minutes post-intervention
Evaluates frequency of negative automatic thoughts from 30 (no symptoms) to 150 (severe symptoms).
Time frame: From baseline to 45 minutes post-intervention
Change from baseline in AAQ-II scores at 45 minutes post-intervention
Evaluates avoidance from 7 (no symptoms) to 49 (severe symptoms).
Time frame: From baseline to 45 minutes post-intervention
Change from baseline in NCBI scores at 45 minutes post-intervention
Evaluates negative core beliefs with higher mean scores representing increased negative core beliefs.
Time frame: From baseline to 45 minutes post-intervention
Change from baseline in PANAS scores at 45 minutes post-intervention
Evaluates positive and negative affect from 10 to 50 with higher scores representing higher levels of positive affect and lower scores representing lower levels of negative affect, respective to their questions.
Time frame: From baseline to 45 minutes post-intervention
Plan to share: Yes — De-identified individual participant data underlying the published results will be made available upon reasonable request.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Data and supporting information will be available beginning 3 months after publication of the study results and will remain accessible for 3 years following the publication date.
Access criteria: Approved investigators will receive access to the de-identified individual participant data and supporting information. To gain access, requestors must submit a research proposal and a signed data use agreement via email to the corresponding author. Requestors whose research proposals have been reviewed and approved by the primary study team will be granted access.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brunel University